FindTrial
Sign In

Budesonide combined Porcine Fibrin Sealant Kit in preventing esophageal stricture after endoscopic submucosal dissection within near-circumferential section of early esophageal cancer: the controlled clinical trial

Budesonide combined Porcine Fibrin Sealant Kit in preventing esophageal stricture after endoscopic submucosal dissection within near-circumferential section of early esophageal cancer: the controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15007314
Enrollment
Unknown
Registered
2015-10-20
Start date
2015-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early esophageal cancer

Interventions

experimental group: Porcine Fibrin Sealant Kit
control group:triamcinolone

Sponsors

Gastroenterology, Xinqiao Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged 18 to 75 years; 2. endoscopic diagnosis of early esophageal cancer or precancerous lesion, lesions was more than two-thirds of the circumferential and the patients decide to undergoing ESD; 3. voluntary participation in clinical research, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. younger than 18 years and older than 75 years; 2. endoscopic therapy; 3. severe bleeding tendencies; 4. Heart, lung, brain, kidney and other vital organ function and hematopoietic function is severely impaire; 5. HIV, syphilis infection or drug addicts; 6. difficult to follow up.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative stenosis;—

Countries

China

Contacts

Public ContactYu Jing
yujing124@163.com+86 13983205131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026